High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma
- 15 March 1991
- Vol. 67 (6) , 1514-1517
- https://doi.org/10.1002/1097-0142(19910315)67:6<1514::aid-cncr2820670609>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanomaCancer, 1989
- Evaluation of cis-Platinum and DTIC Combination Chemotherapy in Disseminated Melanoma A Southwest Oncology Group StudyAmerican Journal of Clinical Oncology, 1988
- WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.Journal of Clinical Oncology, 1987
- Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma IV. Late results after complete response to chemotherapy (central oncology group protocols 7130, 7131, and 7131A)Cancer, 1984
- Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experienceCancer, 1982